This website uses cookies to enhance the user experience.
J

JANDERSEN KAPITAL AS917 611 246

Limited company
Hylkjesvingen 18 5109 HYLKJE, Norge

JANDERSEN KAPITAL AS

Organization

Chairman of the board
Years since formation
8 years
since Aug 24, 2016
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
500
1 share class
Total number of shareholders
2
companies

Financials

Annual total result 2023
-15,432,477
NOK
Total equity 2023
-29,685,244
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
50 %
indirectly

Board

NameRoleShares
Chairman
50 %
indirectly
Board Member
50 %
indirectly

Others

NameRoleShares
S
SIGMA REVISJON AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Chairman
50 %
indirectly
Managing Director/CEO, Board Member
50 %
indirectly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
K
KHN HOLDING AS
Ordinary shares
250
50 %
M
MYRLID AS
Ordinary shares
250
50 %

Shares owned by the JANDERSEN KAPITAL AS

NameShare classNumber of sharesShare
A
ADJUVANT PARTNERS AS
Ordinary shares
200
50 %
H
HUBRO THERAPEUTICS AS
NO0012442260
414,246
10.02 %
N
NEXTERA AS
NO0010848534
53,465
1.46 %
A
ADJUTEC PHARMA AS
Ordinary shares
664
1.45 %
P
PCI BIOTECH HOLDING ASA
NO0010405640
400,000
1.07 %
Z
ZELLUNA IMMUNOTHERAPY AS
NO0010820731
119,850
0.99 %
K
Ordinary shares
46
0.57 %
O
ONCOINVENT ASA
NO0010779341
111,440
0.57 %
U
ULTIMOVACS ASA
NO0010851603
45,000
0.13 %
S
SOFTOX SOLUTIONS AS
NO0010811961
11,500
0.11 %
P
PHOTOCURE ASA
NO0010000045
10,000
0.04 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-15,432,477
-13,187,130
-2,697,939
Total assets
46,966,572
51,799,362
55,534,991
Total liabilities
76,651,816
66,052,129
56,600,628
Total equity
-29,685,244
-14,252,767
-1,065,637

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
1,070,287
1,072,285
1,046,847
Operating result
-1,070,287
-1,072,285
-1,046,847
Financial income/costs
-14,362,190
-12,114,846
-1,651,092
Profit before tax
-15,432,477
-13,187,130
-2,697,939
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-15,432,477
-13,187,130
-2,697,939

Balance overview

Year202320222021
Total fixed assets
10,723,288
6,427,000
0
Total current assets
36,243,284
45,372,362
55,534,991
Total assets
46,966,572
51,799,362
55,534,991
Short term debt
164,125
165,078
163,616
Long term debt
76,487,691
65,887,051
56,437,012
Total liabilities
76,651,816
66,052,129
56,600,628
Contributed capital
500,000
500,000
500,000
Retained earnings
-30,185,244
-14,752,767
-1,565,637
Total equity
-29,685,244
-14,252,767
-1,065,637
Total equity and liabilities
46,966,572
51,799,362
55,534,991

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises